Calcimedica
ID: 5331165Calcimedica is a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.
12
Funding Rounds
$108.1m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Calcimedica has raised a total of $26m in funding over 12 rounds.
Key Insights:
- CalciMedica Series C round, May 2020: $15m
- Calcimedica Series C round: $4m
- Calcimedica Series B round: $5.5m
- Calcimedica Series A round: $1.5m
- CalciMedica Inc funding round, October 2012: $4.6m
- CalciMedica Inc funding round, July 2010: $9m
- CalciMedica Inc funding round, September 2011: $4m
- CalciMedica Inc funding round, March 2012: $13.2m
- CalciMedica Inc funding round, July 2013: $9m
- CalciMedica Inc funding round, April 2014: $13.09m
- CalciMedica Inc funding round, May 2020: $17.19m
- CalciMedica Inc funding round, November 2009: $12m
Industries
Calcimedica is active in the following industries: